MOSAIC – Global NASH Trialist Forum 2023: A Multidisciplinary Approach to NASH Clinical Trials

Engage in an immersive experience of cross-disciplinary knowledge exchange at the upcoming MOSAIC - Global NASH Trialist Forum 2023, an essential gathering committed to addressing Non-alcoholic Steatohepatitis (NASH) through multi-specialty clinical trials
Mosaic Nash Banner June 2024

MOSAIC – Global NASH Trialist Forum: Pioneering NASH Solutions

Scheduled for 19-20 October 2023 at Georgetown University’s Leavey Center, Washington, D.C., the MOSAIC – Global NASH Trialist Forum serves as a crucial think tank. This forum brings together leading cardiologists, endocrinologists, hepatologists, clinical trialists, regulatory experts, patient representatives, and other stakeholders to push the boundaries of our collective understanding of NASH.

The Global Impact of NASH

Non-alcoholic fatty liver disease (NAFLD) and NASH affect approximately 25-30% of the adult population, causing significant health implications. NASH, considered a metabolic and multi-organ disease, is linked to a host of other health complications, including type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), and certain extra-hepatic cancers.

Highlights of MOSAIC – Global NASH Trialist Forum

The MOSAIC – Global NASH Trialist Forum presents a unique opportunity for participants to:

  • Build valuable connections with a diverse group of stakeholders in NASH clinical trials
  • Participate in Think Tank focused workshops, facilitating dynamic discussions and collaborative problem-solving
  • Receive updates on the latest NASH trials and therapeutic advancements
  • Engage with patient representatives for firsthand insights into the patient journey

NASH Trial Expertise and Themes

Expert chairs leading the forum include Javed Butler (USA), Stephen Harrison (USA), Veronica Miller (USA), Naveed Sattar (UK), Arun Sanyal (USA), and Faiez Zannad (France).

Key themes to be addressed during the forum are:

  • Cardiovascular implications of NASH
  • Epidemiology and disease mechanisms in NASH
  • NonInvasive Tests (NITs) in NASH diagnosis
  • Innovative trial design issues for NASH
  • Optimal patient population selection in NASH trials
  • Defining endpoints and pathways to approval for NASH therapeutics
  • Experiences and case studies from previous NASH trials

A Unique Opportunity for NASH Stakeholders

The MOSAIC – Global NASH Trialist Forum 2023 offers an unparalleled platform for knowledge exchange, networking, and collaboration for everyone committed to tackling NASH. Be a part of the solution and join this vital conversation this October.

Share the article
Avatar photo


With a computer science background and a keen insight into the intricacies of health and medicine, Lila is the driving force behind BL Digital. Specializing in disseminating critical information about NASH and related pathologies on the web, her agency crafts compelling websites optimized for SEO and user engagement. When she's not researching the latest developments in NASH or optimizing web content, you might catch her indulging in her love for Trimix diving or unwinding with her trusty PS5.

Articles: 9